$12.38
3.08% yesterday
Nasdaq, Jul 14, 10:00 pm CET
ISIN
US53222K2050
Symbol
LFVN
Sector
Industry

LifeVantage Corporation Stock price

$12.38
-0.38 2.98% 1M
-13.24 51.68% 6M
-5.15 29.38% YTD
+6.12 97.76% 1Y
+8.56 223.80% 3Y
-0.28 2.23% 5Y
+8.82 247.94% 10Y
-43.93 78.01% 20Y
Nasdaq, Closing price Mon, Jul 14 2025
+0.37 3.08%
ISIN
US53222K2050
Symbol
LFVN
Sector
Industry

Key metrics

Basic
Market capitalization
$151.2m
Enterprise Value
$128.7m
Net debt
positive
Cash
$22.5m
Shares outstanding
12.6m
Valuation (TTM | estimate)
P/E
17.2 | 14.7
P/S
0.7 | 0.6
EV/Sales
0.6 | 0.5
EV/FCF
10.7
P/B
4.5
Dividends
DPS
$0.17
Yield 1Y | 5Y
1.4% | 1.2%
Growth 1Y | 5Y
13.8% | -
Payout 1Y | 3Y
237.0% | 103.2%
Increased
4 Years
Financials (TTM | estimate)
Revenue
$222.4m | $234.9m
EBITDA
$16.2m | $22.2m
EBIT
$13.0m | $13.2m
Net Income
$9.2m | $10.3m
Free Cash Flow
$12.0m
Growth (TTM | estimate)
Revenue
8.2% | 17.4%
EBITDA
110.0% | 181.1%
EBIT
222.2% | 204.7%
Net Income
154.2% | 249.3%
Free Cash Flow
10.0%
Margin (TTM | estimate)
Gross
80.3%
EBITDA
7.3% | 9.5%
EBIT
5.8%
Net
4.1% | 4.4%
Free Cash Flow
5.4%
Financial Health
Equity Ratio
43.1%
Return on Equity
11.3%
ROCE
29.0%
ROIC
20.2%
Debt/Equity
0.0
More
EPS
$0.7
FCF per Share
$1.0
Short interest
20.3%
Employees
222
Rev per Employee
$900.0k
Show more

Is LifeVantage Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

LifeVantage Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a LifeVantage Corporation forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a LifeVantage Corporation forecast:

Buy
86%
Hold
14%

Financial data from LifeVantage Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
222 222
8% 8%
100%
- Direct Costs 44 44
3% 3%
20%
179 179
10% 10%
80%
- Selling and Administrative Expenses 166 166
4% 4%
74%
- Research and Development Expense - -
-
-
16 16
110% 110%
7%
- Depreciation and Amortization 3.21 3.21
13% 13%
1%
EBIT (Operating Income) EBIT 13 13
222% 222%
6%
Net Profit 9.15 9.15
154% 154%
4%

In millions USD.

Don't miss a Thing! We will send you all news about LifeVantage Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LifeVantage Corporation Stock News

Neutral
Seeking Alpha
2 months ago
LifeVantage Corporation (NASDAQ:LFVN ) Q3 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Reed Anderson - Managing Director-ICR Steve Fife - President and Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you ...
Neutral
GlobeNewsWire
2 months ago
SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid June 13, 2025 to all stockholders of re...
Neutral
GlobeNewsWire
2 months ago
SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2025. Third Quarter Fiscal 2025 Summary*: Revenue was $58.4 million, an increase of 21.1% from the prior year...
More LifeVantage Corporation News

Company Profile

LifeVantage Corp. engages in the identification, research, development, and distribution of advanced nutraceutical dietary supplements and personal care products. It operates through the Americas Region; and Asia/Pacific and Europe Region georaphical segments. The firm's products include Protandim, LifeVantage® Omega+ and ProBio, TrueScience, and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.

Head office United States
CEO Steven Fife
Employees 222
Founded 1988
Website www.lifevantage.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today